Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The coronary stents market has seen significant growth in recent years, driven by various medical and technological advancements. This sector is expected to continue expanding steadily, supported by rising cardiovascular health concerns and innovations in stent design and materials. Let’s delve into the market’s current size, growth drivers, segmentation, strategic developments, key players, and regional prospects.

Overview of Coronary Stents Market Size and Expected Growth

The coronary stents market has experienced robust growth, increasing from $11.9 billion in 2025 to an anticipated $12.9 billion in 2026. This represents a compound annual growth rate (CAGR) of 8.3%. This positive trend reflects factors such as the growing incidence of coronary artery disease, a rise in percutaneous coronary intervention procedures, improved stent coating technologies, wider availability of interventional cardiology services, and better clinical outcomes associated with coronary stenting.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Future Projections for Coronary Stents Market Expansion

Looking ahead, the coronary stents market is projected to expand further, reaching $17.76 billion by 2030, maintaining a steady CAGR of 8.3%. This anticipated growth stems from an aging population with increased cardiovascular risks, rising demand for minimally invasive cardiac treatments, broader adoption of next-generation stent technologies, greater attention to long-term vessel healing and patient outcomes, and enhanced access to cardiac care, especially in emerging markets. Key trends expected to influence the market include the growing use of drug-eluting and dual therapy stents, preference for minimally invasive procedures, efforts to reduce restenosis and thrombosis, increased utilization of bioresorbable and biodegradable stents, and a rising demand for advanced stent materials and designs.

Primary Factors Driving Growth in the Coronary Stents Market

One of the main factors propelling the coronary stents market is the escalating prevalence of cardiovascular diseases (CVDs). These disorders, involving the heart and blood vessels, include coronary artery disease, heart failure, stroke, and hypertension. The rise in CVD cases is linked to aging populations and an increase in risk factors such as obesity, diabetes, sedentary lifestyles, unhealthy diets, and stress. Coronary stents are essential in treating these conditions by reopening narrowed or blocked arteries, thus improving blood flow to the heart and lowering the risk of heart attacks.

Access The Complete Coronary Stents Market Report:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Healthcare Data Reinforces Market Growth Drivers

For example, in October 2024, the US Centers for Disease Control and Prevention reported that cardiovascular disease caused 919,032 deaths in 2023, accounting for about one in every three deaths nationally. This alarming statistic highlights the critical need for coronary stents, reinforcing their growing demand as a vital treatment option and pushing the market forward.

Detailed Breakdown of Coronary Stents Market Segmentation

This report segments the coronary stents market by various categories:

– Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

– Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, and other technologies

– Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

– Deployment Method: Self-Expandable Stents, Balloon-Expandable Stents

– End Use: Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Other End Uses

The product types are further divided into subcategories such as sirolimus-, paclitaxel-, and everolimus-eluting dual therapy stents; beta and gamma radiation radioactive stents; manual, mechanical, and hydrodynamic thrombectomy stents; various covered stents including PTFE and ePTFE; bioresorbable stents based on polymer, metal, and ceramic; biodegradable stents like polymeric and magnesium-based; hybrid drug-eluting and biodegradable or metal stents; and drug-eluting stents differentiated by their drug types, as well as several types of bare metal stents.

Innovative Trends Defining the Coronary Stents Market’s Future

Leading companies in the market are focusing on developing advanced products, especially drug-eluting stents, which help minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents work by slowly releasing medication to prevent artery re-narrowing. For instance, in May 2024, Abbott, a US healthcare firm, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features enhanced design elements, a novel delivery system, and specialized sizing options to tackle complex cases. It retains the drug-eluting coating that reduces artery re-blockage risk and is supported by an outstanding safety record from over 120 clinical trials involving more than 120,000 patients.

Key Players Shaping the Coronary Stents Market Landscape

The coronary stents market includes a range of prominent companies such as Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, and Minvasys.

Regional Outlook Highlights for the Coronary Stents Market

In 2025, North America was the largest regional market for coronary stents. However, the Asia-Pacific region is expected to emerge as the fastest-growing market during the forecast period. This analysis spans key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a thorough global perspective on market opportunities and trends.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model